Form 8K
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

July 16, 2004

Date of report (date of earliest event reported)

 


 

QUADRAMED CORPORATION

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   0-21031   52-1992861

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of Principal Executive Offices)

 

(703) 709-2300

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former Name or Former address, if Changed Since Last Report)

 



Table of Contents

TABLE OF CONTENTS

 

ITEM 5.   OTHER EVENTS AND REGULATION FD DISCLOSURE
ITEM 7.   FINANCIAL STATEMENTS AND EXHIBITS
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1


Table of Contents

ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE

 

On July 20, 2004, QuadraMed Corporation announced the completion of its cash tender offer to purchase any and all of its outstanding 10% Senior Secured Notes due 2008 (the “Notes”). All of the Notes were purchased, the aggregate purchase price including accrued and unpaid interest was approximately $79.3 million. A copy of the Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1.

 

The information in this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

 

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

 

(c) Exhibits

 

Exhibit No.

 

Description


99.1   Press Release, dated July 20, 2004, announcing completion of QuadraMed’s tender offer with respect to its 10% Senior Secured Notes due 2008.


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 20, 2004

 

QuadraMed Corporation

/s/


John Wright, Executive Vice President,

Chief Financial Officer and Secretary


Table of Contents

EXHIBIT INDEX

 

Exhibit No.

 

Description


99.1   Press Release, dated July 19, 2004, announcing completion of QuadraMed’s tender offer with respect to its 10% Senior Secured Notes due 2008.